NM_001244710.2:c.*6085C>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001244710.2(GFPT1):​c.*6085C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.658 in 152,056 control chromosomes in the GnomAD database, including 34,361 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.66 ( 34359 hom., cov: 32)
Exomes 𝑓: 0.67 ( 2 hom. )

Consequence

GFPT1
NM_001244710.2 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.810

Publications

7 publications found
Variant links:
Genes affected
GFPT1 (HGNC:4241): (glutamine--fructose-6-phosphate transaminase 1) This gene encodes the first and rate-limiting enzyme of the hexosamine pathway and controls the flux of glucose into the hexosamine pathway. The product of this gene catalyzes the formation of glucosamine 6-phosphate. [provided by RefSeq, Sep 2008]
GFPT1 Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 12
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, PanelApp Australia, Illumina, Labcorp Genetics (formerly Invitae)
  • congenital myasthenic syndromes with glycosylation defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 2-69320104-G-C is Benign according to our data. Variant chr2-69320104-G-C is described in ClinVar as Benign. ClinVar VariationId is 336784.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.862 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001244710.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GFPT1
NM_001244710.2
MANE Select
c.*6085C>G
3_prime_UTR
Exon 20 of 20NP_001231639.1Q06210-1
GFPT1
NM_002056.4
c.*6085C>G
3_prime_UTR
Exon 19 of 19NP_002047.2Q06210-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GFPT1
ENST00000357308.9
TSL:5 MANE Select
c.*6085C>G
3_prime_UTR
Exon 20 of 20ENSP00000349860.4Q06210-1
GFPT1
ENST00000361060.5
TSL:1
c.*6085C>G
3_prime_UTR
Exon 19 of 19ENSP00000354347.4Q06210-2

Frequencies

GnomAD3 genomes
AF:
0.658
AC:
99955
AN:
151932
Hom.:
34317
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.870
Gnomad AMI
AF:
0.667
Gnomad AMR
AF:
0.571
Gnomad ASJ
AF:
0.645
Gnomad EAS
AF:
0.466
Gnomad SAS
AF:
0.621
Gnomad FIN
AF:
0.557
Gnomad MID
AF:
0.627
Gnomad NFE
AF:
0.583
Gnomad OTH
AF:
0.629
GnomAD4 exome
AF:
0.667
AC:
4
AN:
6
Hom.:
2
Cov.:
0
AF XY:
1.00
AC XY:
2
AN XY:
2
show subpopulations
African (AFR)
AF:
1.00
AC:
2
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.500
AC:
2
AN:
4
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.658
AC:
100052
AN:
152050
Hom.:
34359
Cov.:
32
AF XY:
0.653
AC XY:
48513
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.870
AC:
36096
AN:
41498
American (AMR)
AF:
0.571
AC:
8720
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.645
AC:
2234
AN:
3464
East Asian (EAS)
AF:
0.466
AC:
2408
AN:
5166
South Asian (SAS)
AF:
0.619
AC:
2980
AN:
4816
European-Finnish (FIN)
AF:
0.557
AC:
5865
AN:
10526
Middle Eastern (MID)
AF:
0.619
AC:
182
AN:
294
European-Non Finnish (NFE)
AF:
0.583
AC:
39618
AN:
67988
Other (OTH)
AF:
0.634
AC:
1341
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1623
3246
4869
6492
8115
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
782
1564
2346
3128
3910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.624
Hom.:
3628
Bravo
AF:
0.666
Asia WGS
AF:
0.593
AC:
2065
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Congenital myasthenic syndrome 12 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.54
DANN
Benign
0.43
PhyloP100
-0.81
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
0.97
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7642; hg19: chr2-69547236; API